Company Overview - BioStem Technologies is a profitable med tech company focused on advanced wound care [2] - The company's core technology is BioREtain, which processes placental-based tissue allografts for advanced wound care [2][3] Market Potential - The target patient population includes approximately 7 million Medicare beneficiaries [3] - The total market for advanced wound care is estimated to be around $11.3 billion [3]